Medical Devices Market
完整報告名稱與涵蓋範圍
Medical Devices Market Size By Type (In Vitro Diagnostic Devices, Cardiovascular, Imaging, Ophthalmology, Endoscopy, Orthopedic, Diabetes Care, Wound Care Devices, Kidney/Dialysis Devices, Respiratory Care) and Region - Global Forecast to 2031
報告摘要
The global medical devices market is projected to reach USD 817.78 billion by 2031 from USD 580.79 billion in 2026, at a CAGR of 7.1%.
The growth of the medical devices market is driven by the increasing prevalence of chronic diseases and the rapidly aging global population, which continues to raise demand for diagnostic, cardiovascular, orthopedic, ophthalmic devices, and other medical devices. However, the high cost of advanced medical devices, including cardiovascular systems, orthopedic implants, and diagnostic equipment, restrains adoption, particularly in developing countries with limited healthcare budgets. The market also faces challenges from stringent regulatory frameworks and lengthy product approval processes, as well as shortages of skilled healthcare professionals capable of operating sophisticated medical technologies, which can delay product adoption and clinical implementation. Despite these barriers, the rapidly developing healthcare infrastructure in emerging economies presents significant growth opportunities. Increasing investments in hospitals, ambulatory surgery centers, diagnostic laboratories, and digital healthcare systems, along with expanding health insurance coverage, are improving access to advanced medical technologies, enabling leading manufacturers to expand their global footprint and strengthen long-term market growth.
“By type, the cardiovascular devices segment held the second-largest share of the medical devices market in 2025.”
Based on type, the medical devices market comprises in vitro diagnostic devices, cardiovascular devices, imaging devices, orthopedic devices, ophthalmology devices, endoscopy devices, diabetes care devices, wound care devices, kidney/dialysis devices, respiratory care devices and other medical devices. Among these, cardiovascular devices held the second-largest share of the market in 2025. This is due to the increasing global burden of cardiovascular diseases (CVDs) and the growing demand for advanced diagnostic and interventional technologies. According to the World Health Organization (WHO), an estimated 19.8 million people died from cardiovascular diseases in 2022, accounting for approximately 32% of all global deaths. Additionally, the US Centers for Disease Control and Prevention (CDC) reported that 919,032 people died from cardiovascular disease in the US in 2023. This high disease burden has significantly increased the adoption of cardiac rhythm management devices, coronary stents, heart valves, catheters, and vascular intervention systems. The rising aging population, along with the increasing prevalence of hypertension, diabetes, and obesity, has led to a greater demand for cardiovascular devices. This demand is further bolstered by a growing preference for minimally invasive cardiovascular procedures and ongoing technological advancements. As a result, the cardiovascular devices segment continues to hold a prominent position in the global medical devices market.
“The US is expected to grow at the highest CAGR in the North American market during the forecast period.”
The medical devices market is divided into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Among these, North America dominated the global medical devices market in 2025. The North American market is further divided into the US and Canada. Among these, the US held the largest share of the North American market in 2025. This is due to its high prevalence of chronic diseases, advanced healthcare infrastructure, substantial healthcare spending, and strong presence of leading medical device manufacturers. According to the US Centers for Disease Control and Prevention (CDC), coronary heart disease, the most common type of heart disease, caused 371,506 deaths in 2022. The CDC also reported in June 2024 that approximately 53 million US adults have arthritis, while CDC data released in 2026 estimated that more than 1 in 10 adults (37 million people) have chronic kidney disease (CKD). This significant disease burden drives sustained demand for cardiovascular, orthopedic, diagnostic, and renal care devices. In addition, the US benefits from the rapid adoption of advanced medical technologies, favorable reimbursement systems, strong research and development investments, and the presence of major medical device company headquarters, which support continuous product innovation and reinforce the country's leadership in the regional medical devices market.
A breakdown of the primary participants (supply side) for the medical devices market referred to in this report is provided below:
• By Company Type: Tier 1 (35%), Tier 2 (40%), and Tier 3 (25%)
• By Designation: C-level Executives (45%), Directors (35%), and Others (20%)
• By Region: North America (27%), Europe (25%), Asia Pacific (30%), Latin America (8%), and the Middle East & Africa (10%)
Prominent players in the medical devices market include Medtronic (Ireland), Johnson & Johnson (US), B. Braun SE (Germany), Olympus Corporation (Japan), GE Healthcare (US), and Boston Scientific (US), among others.
Research Coverage
The report analyzes the medical devices market and estimates its size and future growth potential across segments (type and region). The report also includes a competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report will help market leaders/new entrants in this market by providing revenue estimates for the overall medical devices market. This report will help stakeholders understand the competitive landscape and gain deeper insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key drivers, restraints, challenges, and opportunities.
This report provides insights into the following pointers:
Analysis of key drivers (rising aging population and increasing prevalence of chronic diseases), restraints (high cost of various medical devices), opportunities (rapidly developing healthcare sector in emerging economies), and challenges (shortage of skilled healthcare professionals and stringent regulatory framework).
• Market Penetration: It includes extensive information on the products offered by the major players in the global medical devices market. The report includes various segments: type and region.
• Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global medical devices market.
• Market Development: Thorough knowledge and analysis of the profitable rising markets by type and region.
• Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global medical devices market.
• Competitive Assessment: Thorough evaluation of the market shares, growth plans, product offerings, and capacities of the major competitors in the global medical devices market.
授權報價
| Single User Licence | $8,150 USD |
| Multi User Licence | $10,500 USD |
| Corporate User Licence | $12,500 USD |
| Global User Licence | $15,000 USD |
目錄 Table of Contents
1 INTRODUCTION 24
1.1 STUDY OBJECTIVES 24
1.2 MARKET DEFINITION 24
1.3 STUDY SCOPE 25
1.3.1 MARKETS COVERED & REGIONAL SEGMENTATION 25
1.3.2 INCLUSIONS & EXCLUSIONS 25
1.3.3 YEARS CONSIDERED 26
1.3.4 CURRENCY CONSIDERED 26
1.4 STAKEHOLDERS 27
2 EXECUTIVE SUMMARY 28
2.1 KEY INSIGHTS & MARKET HIGHLIGHTS 28
2.2 KEY MARKET PARTICIPANTS: INSIGHTS & DEVELOPMENTS 29
2.3 DISRUPTIVE TRENDS SHAPING MARKET GROWTH 30
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 31
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 32
3 PREMIUM INSIGHTS 33
3.1 MEDICAL DEVICES MARKET OVERVIEW 33
3.2 MEDICAL DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 34
3.3 MEDICAL DEVICES MARKET: DEVELOPED VS. EMERGING ECONOMIES 35
4 MARKET OVERVIEW 36
4.1 INTRODUCTION 36
4.2 MARKET DYNAMICS 36
4.2.1 IN VITRO DIAGNOSTIC DEVICES MARKET 36
4.2.1.1 Drivers 37
4.2.1.1.1 Gradual shift from centralized testing to point-of-care testing 37
4.2.1.1.2 Growing awareness of early disease diagnosis across emerging countries 37
4.2.1.2 Restraints 37
4.2.1.2.1 Reimbursement pressure and test-price controls 37
4.2.1.3 Opportunities 38
4.2.1.3.1 Expansion of companion diagnostics (CDx) and oncology testing 38
4.2.1.4 Challenges 38
4.2.1.4.1 Operational barriers and data privacy and cybersecurity risks 38
4.2.2 CARDIOVASCULAR DEVICES MARKET 39
4.2.2.1 Drivers 39
4.2.2.1.1 Rising prevalence of cardiovascular diseases 39
4.2.2.2 Restraints 40
4.2.2.2.1 Stringent regulatory guidelines for product approval 40
4.2.2.3 Opportunities 40
4.2.2.3.1 Growing healthcare needs and improving medical infrastructure in emerging countries 40
4.2.2.4 Challenges 40
4.2.2.4.1 Product recalls and device-related safety events 40
4.2.3 IMAGING DEVICES MARKET 41
4.2.3.1 Drivers 41
4.2.3.1.1 Increasing funds, investments, and grants by public-private investors 41
4.2.3.2 Restraints 42
4.2.3.2.1 High cost of diagnostic imaging systems 42
4.2.3.3 Opportunities 42
4.2.3.3.1 Growing adoption of artificial intelligence (AI) and advanced analytics 42
4.2.3.4 Challenges 43
4.2.3.4.1 Increasing adoption of refurbished diagnostic imaging systems 43
4.2.4 ORTHOPEDIC DEVICES MARKET 43
4.2.4.1 Drivers 44
4.2.4.1.1 Rising prevalence of orthopedic diseases 44
4.2.4.2 Restraints 44
4.2.4.2.1 Risks and complications associated with orthopedic surgical procedures 44
4.2.4.2.2 High cost of orthopedic devices and surgical procedures 44
4.2.4.3 Opportunities 45
4.2.4.3.1 Increasing adoption of robotics and 3D printing in orthopedics 45
4.2.4.4 Challenges 45
4.2.4.4.1 Shortage of orthopedic surgeons 45
4.2.5 OPHTHALMOLOGY DEVICES MARKET 46
4.2.5.1 Drivers 46
4.2.5.1.1 Rising prevalence of eye disorders 46
4.2.5.2 Restraints 47
4.2.5.2.1 High cost & potential risks associated with eye surgery 47
4.2.5.3 Opportunities 47
4.2.5.3.1 Growing adoption of minimally invasive ophthalmic surgical procedures 47
4.2.5.4 Challenges 47
4.2.5.4.1 Low accessibility to eye care services in emerging and low-income countries 47
4.2.6 ENDOSCOPY DEVICES MARKET 48
4.2.6.1 Drivers 48
4.2.6.1.1 Rising investments, funding, and grants for endoscopy procedures 48
4.2.6.1.2 Increasing incidence of inflammatory bowel disease (IBD) and colorectal cancer 49
4.2.6.2 Restraints 49
4.2.6.2.1 High overhead cost and procedural risks associated with endoscopy 49
4.2.6.3 Opportunities 49
4.2.6.3.1 Rapidly developing healthcare sector in emerging economies 49
4.2.6.4 Challenges 50
4.2.6.4.1 Increasing number of product recalls 50
4.2.6.5 Lack of proper sterilization and reprocessing 51
4.2.7 DIABETES CARE DEVICES MARKET 52
4.2.7.1 Drivers 52
4.2.7.1.1 Increasing prevalence of diabetes 52
4.2.7.2 Restraints 53
4.2.7.2.1 High cost of advanced diabetes care devices 53
4.2.7.3 Opportunities 53
4.2.7.3.1 Increasing adoption of advanced implantable continuous glucose monitoring (CGM) devices 53
4.2.7.4 Challenges 53
4.2.7.4.1 High costs and socioeconomic disparities 53
4.2.8 WOUND CARE DEVICES MARKET 54
4.2.8.1 Drivers 54
4.2.8.1.1 Rising incidents of traumatic injuries and burn cases 54
4.2.8.2 Restraints 55
4.2.8.2.1 Risks associated with advanced wound care 55
4.2.8.3 Opportunities 55
4.2.8.3.1 Growth potential in emerging economies 55
4.2.8.4 Challenges 55
4.2.8.4.1 Shortage of trained professionals and limited access to wound care devices 55
4.2.9 KIDNEY/DIALYSIS DEVICES MARKET 56
4.2.9.1 Drivers 56
4.2.9.1.1 Rising prevalence of chronic kidney disease (CKD) 56
4.2.9.2 Restraints 57
4.2.9.2.1 Risks, complications, and high procedural costs associated with dialysis treatments 57
4.2.9.3 Opportunities 57
4.2.9.3.1 Increasing number of dialysis centers in emerging economies 57
4.2.9.4 Challenges 57
4.2.9.4.1 Increasing number of product recalls and growing preference for renal transplantation 57
4.2.10 RESPIRATORY CARE DEVICES MARKET 58
4.2.10.1 Drivers 58
4.2.10.1.1 Rising prevalence of chronic respiratory disease 58
4.2.10.2 Restraints 59
4.2.10.2.1 Unfavorable reimbursement scenario 59
4.2.10.3 Opportunities 59
4.2.10.3.1 High growth in developing countries across Asia Pacific and Latin America 59
4.2.10.4 Challenges 59
4.2.10.4.1 Harmful effects of certain devices on neonates 59
4.3 UNMET NEEDS & WHITE SPACES 60
4.3.1 UNMET NEEDS IN MEDICAL DEVICES MARKET 60
4.3.2 WHITE SPACE OPPORTUNITIES 60
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 61
4.4.1 INTERCONNECTED MARKETS 61
4.4.2 CROSS-SECTOR OPPORTUNITIES 61
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 62
5 INDUSTRY TRENDS 63
5.1 PORTER’S FIVE FORCES ANALYSIS 63
5.1.1 THREAT OF NEW ENTRANTS 64
5.1.2 THREAT OF SUBSTITUTES 65
5.1.3 BARGAINING POWER OF BUYERS 65
5.1.4 BARGAINING POWER OF SUPPLIERS 65
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 65
5.2 MACROECONOMIC OUTLOOK 66
5.2.1 INTRODUCTION 66
5.2.2 GDP TRENDS & FORECAST 66
5.2.3 TRENDS IN MINIMALLY INVASIVE SURGERY (MIS) INDUSTRY 68
5.2.4 TRENDS IN SURGICAL ROBOTS INDUSTRY 68
5.3 SUPPLY CHAIN ANALYSIS 69
5.4 VALUE CHAIN ANALYSIS 70
5.5 ECOSYSTEM ANALYSIS 71
5.6 PRICING ANALYSIS 72
5.6.1 AVERAGE SELLING PRICE TREND OF MEDICAL DEVICES, BY KEY PLAYER (2023–2025) 72
5.6.2 AVERAGE SELLING PRICE TREND OF MEDICAL DEVICES, BY REGION
(2023–2025) 73
5.7 TRADE ANALYSIS 73
5.7.1 IMPORT SCENARIO (HS CODE 9018) 73
5.7.2 EXPORT DATA (HS CODE 9018) 74
5.8 KEY CONFERENCES & EVENTS, 2026–2027 75
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 76
5.10 INVESTMENT & FUNDING SCENARIO 76
5.11 IMPACT OF 2025 US TARIFFS ON MEDICAL DEVICES MARKET 77
5.11.1 INTRODUCTION 77
5.11.2 KEY TARIFF RATES 78
5.11.3 PRICE IMPACT ANALYSIS 79
5.11.4 IMPACT ON COUNTRIES/REGIONS 79
5.11.4.1 North America 79
5.11.4.2 Europe 79
5.11.4.3 Asia Pacific 80
5.11.5 END-USE INDUSTRY IMPACT 80
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 81
6.1 KEY EMERGING TECHNOLOGIES 81
6.1.1 ROBOTIC-ASSISTED & COMPUTER-ASSISTED INTERVENTIONS 81
6.1.2 POINT-OF-CARE (POC) & MINIATURIZED DIAGNOSTICS 81
6.2 COMPLEMENTARY TECHNOLOGIES 82
6.2.1 DIGITAL INTERNET OF MEDICAL THINGS (IOMT) & CLOUD CONNECTIVITY 82
6.3 TECHNOLOGY/PRODUCT ROADMAP 82
6.3.1 SHORT TERM (2025–2027) | FOUNDATION & EARLY COMMERCIALIZATION 82
6.3.2 MID TERM (2027–2030) | EXPANSION & STANDARDIZATION 83
6.3.3 LONG TERM (2030–2035+) | MASS COMMERCIALIZATION & DISRUPTION 83
6.4 PATENT ANALYSIS 84
6.4.1 INSIGHTS: JURISDICTION & TOP APPLICANT ANALYSIS 85
6.5 FUTURE APPLICATIONS 85
6.6 IMPACT OF AI/GEN AI ON MEDICAL DEVICES MARKET 86
6.6.1 TOP USE CASES & MARKET POTENTIAL 87
6.6.2 CASE STUDIES OF AI IMPLEMENTATION IN MEDICAL DEVICES MARKET 87
6.6.3 INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS 88
6.6.4 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN MEDICAL
DEVICES MARKET 88
7 SUSTAINABILITY & REGULATORY LANDSCAPE 89
7.1 REGIONAL REGULATIONS & COMPLIANCE 89
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 89
7.1.2 INDUSTRY STANDARDS 91
7.2 SUSTAINABILITY INITIATIVES 92
7.2.1 CARBON IMPACT & ECO-APPLICATIONS OF MEDICAL DEVICES MARKET 92
7.2.1.1 Carbon impact reduction 92
7.2.1.2 Eco-applications 92
7.3 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES 93
7.4 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 93
7.5 REIMBURSEMENT ANALYSIS 94
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 96
8.1 DECISION-MAKING PROCESS 96
8.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA 96
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 96
8.2.2 KEY BUYING CRITERIA 97
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 98
8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 98
8.5 MARKET PROFITABILITY 99
8.5.1 REVENUE POTENTIAL 99
8.5.2 COST DYNAMICS 99
8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS 99
9 MEDICAL DEVICES MARKET, BY TYPE 100
9.1 INTRODUCTION 101
9.2 IN VITRO DIAGNOSTIC DEVICES 102
9.2.1 WIDESPREAD DIAGNOSTIC TESTING TO DRIVE DEMAND FOR IN VITRO DIAGNOSTIC DEVICES 102
9.3 CARDIOVASCULAR DEVICES 103
9.3.1 RISING CARDIOVASCULAR DISEASE BURDEN TO DRIVE DEMAND FOR CARDIOVASCULAR DEVICES 103
9.4 WOUND CARE DEVICES 104
9.4.1 RISING PREVALENCE OF CHRONIC WOUNDS AND ADVANCED WOUND MANAGEMENT TO DRIVE WOUND CARE DEVICE ADOPTION 104
9.5 RESPIRATORY CARE DEVICES 105
9.5.1 SHIFT TOWARD HOME-BASED RESPIRATORY MANAGEMENT AND NONINVASIVE THERAPIES TO DRIVE DEVICE ADOPTION 105
9.6 ORTHOPEDIC DEVICES 107
9.6.1 GROWING MUSCULOSKELETAL DISEASE BURDEN AND ADVANCES IN RECONSTRUCTIVE SURGERY TO SUPPORT MARKET GROWTH 107
9.7 KIDNEY/DIALYSIS DEVICES 108
9.7.1 RISING BURDEN OF CHRONIC KIDNEY DISEASE AND EXPANDING RENAL REPLACEMENT THERAPIES TO BOOST GROWTH 108
9.8 DIABETES CARE DEVICES 109
9.8.1 RISING DIABETES PREVALENCE AND ADVANCES IN CONTINUOUS GLUCOSE MONITORING TO FUEL GROWTH 109
9.9 ENDOSCOPY DEVICES 111
9.9.1 GROWING DEMAND FOR MINIMALLY INVASIVE DIAGNOSIS AND THERAPY TO CONTRIBUTE TO MARKET GROWTH 111
9.10 OPHTHALMOLOGY DEVICES 112
9.10.1 RISING GLOBAL BURDEN OF VISION IMPAIRMENT TO BOOST MARKET GROWTH 112
9.11 IMAGING DEVICES 113
9.11.1 GROWING DEMAND FOR ADVANCED DIAGNOSTIC IMAGING O FUEL GROWTH 113
9.12 OTHER MEDICAL DEVICES 114
10 MEDICAL DEVICES MARKET, BY REGION 116
10.1 INTRODUCTION 117
10.2 NORTH AMERICA 119
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 119
10.2.2 US 121
10.2.2.1 US to hold major share in North American medical devices market 121
10.2.3 CANADA 122
10.2.3.1 Growing chronic disease burden and aging population to support Canada’s market 122
10.3 EUROPE 123
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 123
10.3.2 GERMANY 124
10.3.2.1 Germany's leadership in medtech manufacturing, hospital modernization, and aging population to support market expansion 124
10.3.3 UK 125
10.3.3.1 NHS diagnostic modernization and medtech innovation to accelerate market growth 125
10.3.4 FRANCE 126
10.3.4.1 France's emphasis on early diagnosis and specialized care to drive medical device demand 126
10.3.5 ITALY 127
10.3.5.1 Hospital technology modernization and expanding surgical care to drive medical device demand 127
10.3.6 SPAIN 128
10.3.6.1 Digital transformation of national health system to accelerate medical device adoption 128
10.3.7 REST OF EUROPE 129
10.4 ASIA PACIFIC 130
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 130
10.4.2 CHINA 132
10.4.2.1 Healthcare capacity expansion to drive medical device demand in China 132
10.4.3 JAPAN 133
10.4.3.1 Healthy aging policies and advanced healthcare delivery to drive market growth 133
10.4.4 INDIA 134
10.4.4.1 Expanding specialty healthcare access to drive medical device demand 134
10.4.5 AUSTRALIA 135
10.4.5.1 Expanding access to specialist healthcare services to support market growth 135
10.4.6 SOUTH KOREA 136
10.4.6.1 Biohealth innovation and AI-enabled healthcare to drive adoption 136
10.4.7 REST OF ASIA PACIFIC 137
10.5 LATIN AMERICA 138
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 138
10.5.2 BRAZIL 140
10.5.2.1 Strengthening domestic healthcare innovation and medical device production to boost market 140
10.5.3 MEXICO 141
10.5.3.1 Medical technology manufacturing expansion to support growth 141
10.5.4 REST OF LATIN AMERICA 142
10.6 MIDDLE EAST & AFRICA 143
10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 143
10.6.2 GCC COUNTRIES 144
10.6.2.1 Healthcare transformation programs and smart hospital initiatives to drive medical device demand 144
10.6.3 REST OF MIDDLE EAST & AFRICA 145
11 COMPETITIVE LANDSCAPE 147
11.1 INTRODUCTION 147
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 147
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL DEVICES MARKET 148
11.3 REVENUE ANALYSIS, 2021–2025 149
11.4 MARKET SHARE ANALYSIS, 2025 150
11.4.1 GLOBAL IN VITRO DIAGNOSTIC DEVICES MARKET SHARE ANALYSIS, 2025 150
11.4.2 GLOBAL CARDIOVASCULAR DEVICES MARKET SHARE ANALYSIS, 2025 150
11.4.3 GLOBAL ORTHOPEDIC DEVICES MARKET SHARE ANALYSIS, 2025 151
11.4.4 GLOBAL DIABETES CARE DEVICES MARKET SHARE ANALYSIS, 2025 152
11.4.5 GLOBAL ENDOSCOPY DEVICES MARKET SHARE ANALYSIS, 2025 152
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 154
11.5.1 STARS 154
11.5.2 EMERGING LEADERS 154
11.5.3 PERVASIVE PLAYERS 154
11.5.4 PARTICIPANTS 154
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 156
11.5.5.1 Company footprint 156
11.5.5.2 Region footprint 157
11.5.5.3 Type footprint 158
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 160
11.6.1 PROGRESSIVE COMPANIES 160
11.6.2 RESPONSIVE COMPANIES 160
11.6.3 DYNAMIC COMPANIES 160
11.6.4 STARTING BLOCKS 160
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 162
11.6.5.1 Detailed list of key startups/SMEs 162
11.6.5.2 Competitive benchmarking of key startups/SMEs 163
11.7 COMPANY VALUATION & FINANCIAL METRICS 165
11.7.1 FINANCIAL METRICS 165
11.7.2 COMPANY VALUATION 165
11.8 BRAND/PRODUCT COMPARISON 166
11.9 COMPETITIVE SCENARIO 167
11.9.1 PRODUCT LAUNCHES & APPROVALS 167
11.9.2 DEALS 171
11.9.3 EXPANSION 173
12 COMPANY PROFILES 175
12.1 KEY PLAYERS 175
12.1.1 MEDTRONIC PLC 175
12.1.1.1 Business overview 175
12.1.1.2 Products offered 176
12.1.1.3 Recent developments 178
12.1.1.3.1 Product launches & approvals 178
12.1.1.4 MnM view 178
12.1.1.4.1 Right to win 178
12.1.1.4.2 Strategic choices 178
12.1.1.4.3 Weaknesses & competitive threats 179
12.1.2 JOHNSON & JOHNSON 180
12.1.2.1 Business overview 180
12.1.2.2 Products offered 181
12.1.2.3 Recent developments 182
12.1.2.3.1 Product launches & approvals 182
12.1.2.3.2 Deals 183
12.1.2.3.3 Expansions 184
12.1.2.4 MnM view 184
12.1.2.4.1 Right to win 184
12.1.2.4.2 Strategic choices 185
12.1.2.4.3 Weaknesses & competitive threats 185
12.1.3 ABBOTT 186
12.1.3.1 Business overview 186
12.1.3.2 Products offered 187
12.1.3.3 Recent developments 188
12.1.3.3.1 Product launches & approvals 188
12.1.3.3.2 Deals 189
12.1.3.3.3 Expansions 190
12.1.4 KONINKLIJKE PHILIPS N.V. 191
12.1.4.1 Business overview 191
12.1.4.2 Products offered 192
12.1.4.3 Recent developments 193
12.1.4.3.1 Product launches 193
12.1.4.3.2 Deals 194
12.1.4.3.3 Expansions 194
12.1.5 SIEMENS HEALTHINEERS AG 195
12.1.5.1 Business overview 195
12.1.5.2 Products offered 196
12.1.5.3 Recent developments 197
12.1.5.3.1 Product launches & approvals 197
12.1.5.3.2 Deals 198
12.1.5.3.3 Expansions 199
12.1.6 STRYKER CORPORATION 201
12.1.6.1 Business overview 201
12.1.6.2 Products offered 202
12.1.6.3 Recent developments 203
12.1.6.3.1 Deals 203
12.1.7 B. BRAUN SE 204
12.1.7.1 Business overview 204
12.1.7.2 Products offered 205
12.1.7.3 Recent developments 206
12.1.7.3.1 Deals 206
12.1.7.3.2 Expansions 207
12.1.7.4 MnM view 207
12.1.7.4.1 Right to win 207
12.1.7.4.2 Strategic choices 207
12.1.7.4.3 Weaknesses & competitive threats 207
12.1.8 SMITH & NEPHEW 208
12.1.8.1 Business overview 208
12.1.8.2 Products offered 209
12.1.8.3 Recent developments 210
12.1.8.3.1 Product launches 210
12.1.9 BOSTON SCIENTIFIC CORPORATION 211
12.1.9.1 Business overview 211
12.1.9.2 Products offered 212
12.1.9.3 Recent developments 213
12.1.9.3.1 Product approvals 213
12.1.9.3.2 Deals 215
12.1.10 F. HOFFMANN-LA ROCHE LTD. 216
12.1.10.1 Business overview 216
12.1.10.2 Products offered 217
12.1.10.3 Recent developments 218
12.1.10.3.1 Product launches & approvals 218
12.1.10.3.2 Deals 219
12.2 OTHER PLAYERS 220
12.2.1 BECTON, DICKINSON AND COMPANY 220
12.2.2 BAXTER INTERNATIONAL, INC. 221
12.2.3 ZIMMER BIOMET HOLDINGS, INC. 222
12.2.4 OLYMPUS CORPORATION 223
12.2.5 TERUMO CORPORATION 224
12.2.6 FUJIFILM CORPORATION 225
12.2.7 DANAHER CORPORATION 226
12.2.8 FRESENIUS SE & CO. KGAA 227
12.2.9 TELEFLEX INCORPORATED 228
12.2.10 GE HEALTHCARE TECHNOLOGIES INC. 229
12.2.11 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. 230
12.2.12 DEXCOM, INC. 231
12.2.13 THERMO FISHER SCIENTIFIC INC. 232
12.2.14 ALCON INC. 233
12.2.15 NIPRO CORPORATION 234
13 RESEARCH METHODOLOGY 235
13.1 RESEARCH DATA 235
13.1.1 SECONDARY DATA 235
13.1.1.1 Key data from secondary sources 237
13.1.2 PRIMARY DATA 237
13.1.2.1 Key data from primary sources 239
13.1.2.2 Key industry insights 239
13.2 MARKET SIZE ESTIMATION 240
13.3 MARKET BREAKDOWN & DATA TRIANGULATION 244
13.4 MARKET RANKING ANALYSIS 245
13.5 STUDY ASSUMPTIONS 246
13.6 RESEARCH LIMITATIONS 246
13.6.1 METHODOLOGY-RELATED LIMITATIONS 246
13.6.2 SCOPE-RELATED LIMITATIONS 246
13.7 RISK ASSESSMENT 247
14 APPENDIX 248
14.1 DISCUSSION GUIDE 248
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 252
14.3 CUSTOMIZATION OPTIONS 254
14.4 RELATED REPORTS 254
14.5 AUTHOR DETAILS 255
圖表清單 List of Tables & Figures
TABLE 1 MEDICAL DEVICES MARKET: INCLUSIONS & EXCLUSIONS 25
TABLE 2 STANDARD CURRENCY CONVERSION RATES 27
TABLE 3 LIST OF INVESTMENT FOR IMAGING DEVICES 42
TABLE 4 LIST OF RECALLS BY KEY PLAYERS 50
TABLE 5 MEDICAL DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 63
TABLE 6 GDP PERCENTAGE CHANGE, BY KEY COUNTRY, 2021–2030 67
TABLE 7 AVERAGE SELLING PRICE TREND OF MEDICAL DEVICES, BY KEY PLAYER,
2023–2025 (USD) 72
TABLE 8 AVERAGE PRICING TREND OF MEDICAL DEVICES, BY REGION, 2023–2025 (USD) 73
TABLE 9 IMPORT DATA FOR MEDICAL DEVICES UNDER HS CODE 9018, BY COUNTRY, 2019–2024 (USD THOUSAND) 73
TABLE 10 EXPORT DATA FOR MEDICAL DEVICES UNDER HS CODE 9018, BY COUNTRY, 2019–2024 (USD THOUSAND) 74
TABLE 11 MEDICAL DEVICES MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS (2026–2027) 75
TABLE 12 US-ADJUSTED RECIPROCAL TARIFF RATES 78
TABLE 13 KEY PRODUCT-RELATED TARIFFS EFFECTIVE FOR MEDICAL DEVICES 79
TABLE 14 AI-ENABLED DIAGNOSTICS, DIGITAL HEALTH, AND PRECISION MEDICINE 85
TABLE 15 CONNECTED MEDICAL DEVICES, REMOTE MONITORING, AND
SMART HEALTHCARE ECOSYSTEMS 86
TABLE 16 TOP USE CASES & MARKET POTENTIAL 87
TABLE 17 MEDICAL DEVICES MARKET: CASE STUDIES RELATED TO AI IMPLEMENTATION 87
TABLE 18 INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS 88
TABLE 19 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 89
TABLE 20 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 89
TABLE 21 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90
TABLE 22 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90
TABLE 23 MIDDLE EAST & AFRICA AND GCC COUNTRIES: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 91
TABLE 24 GLOBAL STANDARDS IN MEDICAL DEVICES MARKET 91
TABLE 25 CERTIFICATIONS, LABELING, AND ECO-STANDARDS IN MEDICAL DEVICES MARKET 93
TABLE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MEDICAL DEVICES 97
TABLE 27 KEY BUYING CRITERIA FOR TOP THREE MEDICAL DEVICES 97
TABLE 28 MEDICAL DEVICES MARKET: UNMET NEEDS/END-USER EXPECTATIONS 98
TABLE 29 MEDICAL DEVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 101
TABLE 30 IN VITRO DIAGNOSTIC DEVICES MARKET, BY COUNTRY, 2024–2031 (USD BILLION) 102
TABLE 31 CARDIOVASCULAR DEVICES MARKET, BY COUNTRY, 2024–2031 (USD BILLION) 103
TABLE 32 WOUND CARE DEVICES MARKET, BY COUNTRY, 2024–2031 (USD BILLION) 104
TABLE 33 RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2024–2031 (USD BILLION) 106
TABLE 34 ORTHOPEDIC DEVICES MARKET, BY COUNTRY, 2024–2031 (USD BILLION) 107
TABLE 35 KIDNEY/DIALYSIS DEVICES MARKET, BY COUNTRY, 2024–2031 (USD BILLION) 108
TABLE 36 DIABETES CARE DEVICES MARKET, BY COUNTRY, 2024–2031 (USD BILLION) 110
TABLE 37 ENDOSCOPY DEVICES MARKET, BY COUNTRY, 2024–2031 (USD BILLION) 111
TABLE 38 OPHTHALMOLOGY DEVICES MARKET, BY COUNTRY, 2024–2031 (USD BILLION) 112
TABLE 39 IMAGING DEVICES MARKET, BY COUNTRY, 2024–2031 (USD BILLION) 114
TABLE 40 OTHER MEDICAL DEVICES MARKET, BY COUNTRY, 2024–2031 (USD BILLION) 115
TABLE 41 MEDICAL DEVICES MARKET, BY REGION, 2024–2031 (USD BILLION) 118
TABLE 42 NORTH AMERICA: MEDICAL DEVICES MARKET, BY COUNTRY,
2024–2031 (USD BILLION) 120
TABLE 43 NORTH AMERICA: MEDICAL DEVICES MARKET, BY TYPE,
2024–2031 (USD BILLION) 120
TABLE 44 US: MEDICAL DEVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 121
TABLE 45 CANADA: MEDICAL DEVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 122
TABLE 46 EUROPE: MEDICAL DEVICES MARKET, BY COUNTRY, 2024–2031 (USD BILLION) 123
TABLE 47 EUROPE: MEDICAL DEVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 124
TABLE 48 GERMANY: MEDICAL DEVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 125
TABLE 49 UK: MEDICAL DEVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 126
TABLE 50 FRANCE: MEDICAL DEVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 127
TABLE 51 ITALY: MEDICAL DEVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 128
TABLE 52 SPAIN: MEDICAL DEVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 129
TABLE 53 REST OF EUROPE: MEDICAL DEVICES MARKET, BY TYPE,
2024–2031 (USD BILLION) 130
TABLE 54 ASIA PACIFIC: MEDICAL DEVICES MARKET, BY COUNTRY,
2024–2031 (USD BILLION) 131
TABLE 55 ASIA PACIFIC: MEDICAL DEVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 132
TABLE 56 CHINA: MEDICAL DEVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 133
TABLE 57 JAPAN: MEDICAL DEVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 134
TABLE 58 INDIA: MEDICAL DEVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 135
TABLE 59 AUSTRALIA: MEDICAL DEVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 136
TABLE 60 SOUTH KOREA: MEDICAL DEVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 137
TABLE 61 REST OF ASIA PACIFIC: MEDICAL DEVICES MARKET, BY TYPE,
2024–2031 (USD BILLION) 138
TABLE 62 LATIN AMERICA: MEDICAL DEVICES MARKET, BY COUNTRY,
2024–2031 (USD BILLION) 139
TABLE 63 LATIN AMERICA: MEDICAL DEVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 139
TABLE 64 BRAZIL: MEDICAL DEVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 140
TABLE 65 MEXICO: MEDICAL DEVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 141
TABLE 66 REST OF LATIN AMERICA: MEDICAL DEVICES MARKET, BY TYPE,
2024–2031 (USD BILLION) 142
TABLE 67 MIDDLE EAST & AFRICA: MEDICAL DEVICES MARKET, BY REGION,
2024–2031 (USD BILLION) 143
TABLE 68 MIDDLE EAST & AFRICA: MEDICAL DEVICES MARKET, BY TYPE,
2024–2031 (USD BILLION) 144
TABLE 69 GCC COUNTRIES: MEDICAL DEVICES MARKET, BY TYPE,
2024–2031 (USD BILLION) 145
TABLE 70 REST OF MIDDLE EAST & AFRICA: MEDICAL DEVICES MARKET, BY TYPE,
2024–2031 (USD BILLION) 146
TABLE 71 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN MEDICAL
DEVICES MARKET 148
TABLE 72 MEDICAL DEVICES MARKET: REGION FOOTPRINT 157
TABLE 73 MEDICAL DEVICES MARKET: TYPE FOOTPRINT 158
TABLE 74 MEDICAL DEVICES MARKET: DETAILED LIST OF KEY STARTUPS/SMES 162
TABLE 75 MEDICAL DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 163
TABLE 76 MEDICAL DEVICES MARKET: PRODUCT LAUNCHES & APPROVALS, J
ANUARY 2022–JUNE 2026 167
TABLE 77 MEDICAL DEVICES MARKET: DEALS, JANUARY 2022–JUNE 2026 171
TABLE 78 MEDICAL DEVICES MARKET: EXPANSION, JANUARY 2022–JUNE 2026 173
TABLE 79 MEDTRONIC PLC: COMPANY OVERVIEW 175
TABLE 80 MEDTRONIC PLC: PRODUCTS OFFERED 176
TABLE 81 MEDTRONIC PLC: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021–JUNE 2026 178
TABLE 82 JOHNSON & JOHNSON: COMPANY OVERVIEW 180
TABLE 83 JOHNSON & JOHNSON: PRODUCTS OFFERED 181
TABLE 84 JOHNSON & JOHNSON: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021–JUNE 2026 182
TABLE 85 JOHNSON & JOHNSON: DEALS, JANUARY 2021–JUNE 2026 183
TABLE 86 JOHNSON & JOHNSON: EXPANSIONS, JANUARY 2021–JUNE 2026 184
TABLE 87 ABBOTT: COMPANY OVERVIEW 186
TABLE 88 ABBOTT: PRODUCTS OFFERED 187
TABLE 89 ABBOTT: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JUNE 2026 188
TABLE 90 ABBOTT: DEALS, JANUARY 2022–JUNE 2026 189
TABLE 91 ABBOTT: EXPANSIONS, JANUARY 2022–JUNE 2026 190
TABLE 92 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 191
TABLE 93 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED 192
TABLE 94 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES, JANUARY 2022–JUNE 2026 193
TABLE 95 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2022–JUNE 2026 194
TABLE 96 KONINKLIJKE PHILIPS N.V.: EXPANSIONS, JANUARY 2022–JUNE 2026 194
TABLE 97 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW 195
TABLE 98 SIEMENS HEALTHINEERS AG: PRODUCTS OFFERED 196
TABLE 99 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022–JUNE 2026 197
TABLE 100 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2021–JUNE 2026 198
TABLE 101 SIEMENS HEALTHINEERS AG: EXPANSIONS, JANUARY 2021–JUNE 2026 199
TABLE 102 STRYKER CORPORATION: COMPANY OVERVIEW 201
TABLE 103 STRYKER CORPORATION: PRODUCTS OFFERED 202
TABLE 104 STRYKER CORPORATION: DEALS, JANUARY 2021–JUNE 2026 203
TABLE 105 B. BRAUN SE: COMPANY OVERVIEW 204
TABLE 106 B. BRAUN SE: PRODUCTS OFFERED 205
TABLE 107 B. BRAUN SE: DEALS, JANUARY 2021–JUNE 2026 206
TABLE 108 B. BRAUN SE: EXPANSIONS, JANUARY 2021–JUNE 2026 207
TABLE 109 SMITH & NEPHEW: COMPANY OVERVIEW 208
TABLE 110 SMITH & NEPHEW: PRODUCTS OFFERED 209
TABLE 111 SMITH & NEPHEW: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2026 210
TABLE 112 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 211
TABLE 113 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED 212
TABLE 114 BOSTON SCIENTIFIC CORPORATION: PRODUCT APPROVALS, J
ANUARY 2021–JUNE 2026 213
TABLE 115 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2022–JUNE 2026 215
TABLE 116 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW 216
TABLE 117 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS OFFERED 217
TABLE 118 F. HOFFMANN-LA ROCHE LTD.: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022–JUNE 2026 218
TABLE 119 F. HOFFMANN-LA ROCHE LTD.: DEALS, JANUARY 2022–JUNE 2026 219
TABLE 120 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW 220
TABLE 121 BAXTER INTERNATIONAL, INC.: BUSINESS OVERVIEW 221
TABLE 122 ZIMMER BIOMET HOLDINGS, INC.: BUSINESS OVERVIEW 222
TABLE 123 OLYMPUS CORPORATION: BUSINESS OVERVIEW 223
TABLE 124 TERUMO CORPORATION: BUSINESS OVERVIEW 224
TABLE 125 FUJIFILM CORPORATION: BUSINESS OVERVIEW 225
TABLE 126 DANAHER CORPORATION: BUSINESS OVERVIEW 226
TABLE 127 FRESENIUS SE & CO. KGAA: BUSINESS OVERVIEW 227
TABLE 128 TELEFLEX INCORPORATED: BUSINESS OVERVIEW 228
TABLE 129 GE HEALTHCARE TECHNOLOGIES INC.: BUSINESS OVERVIEW 229
TABLE 130 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: BUSINESS OVERVIEW 230
TABLE 131 DEXCOM, INC.: BUSINESS OVERVIEW 231
TABLE 132 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW 232
TABLE 133 ALCON INC.: BUSINESS OVERVIEW 233
TABLE 134 NIPRO CORPORATION: BUSINESS OVERVIEW 234
TABLE 135 MEDICAL DEVICES MARKET: STUDY ASSUMPTIONS 246
TABLE 136 MEDICAL DEVICES MARKET: RISK ASSESSMENT ANALYSIS 247
FIGURE 1 MEDICAL DEVICES MARKET SEGMENTATION & REGIONAL SCOPE 25
FIGURE 2 KEY INSIGHTS & MARKET HIGHLIGHTS 28
FIGURE 3 MEDICAL DEVICES MARKET, 2026 – 2031 28
FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL DEVICES MARKET 29
FIGURE 5 DISRUPTIVE TRENDS IMPACTING GROWTH OF MEDICAL DEVICES MARKET 30
FIGURE 6 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS IN MEDICAL DEVICES MARKET, 2025 31
FIGURE 7 NORTH AMERICA TO HOLD LARGEST MARKET SHARE IN 2025 32
FIGURE 8 RISING PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET GROWTH 33
FIGURE 9 INDIA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 34
FIGURE 10 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 35
FIGURE 11 IN VITRO DIAGNOSTIC DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 36
FIGURE 12 CARDIOVASCULAR DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 39
FIGURE 13 IMAGING DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 41
FIGURE 14 ORTHOPEDIC DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 43
FIGURE 15 OPHTHALMOLOGY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 46
FIGURE 16 ENDOSCOPY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 48
FIGURE 17 DIABETES CARE DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 52
FIGURE 18 WOUND CARE DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 54
FIGURE 19 KIDNEY/DIALYSIS DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 56
FIGURE 20 RESPIRATORY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 58
FIGURE 21 MEDICAL DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 64
FIGURE 22 MEDICAL DEVICES MARKET: SUPPLY CHAIN ANALYSIS 70
FIGURE 23 MEDICAL DEVICES MARKET: VALUE CHAIN ANALYSIS 71
FIGURE 24 MEDICAL DEVICES MARKET: ECOSYSTEM ANALYSIS 72
FIGURE 25 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 76
FIGURE 26 MEDICAL DEVICES MARKET: INVESTMENT & FUNDING SCENARIO 77
FIGURE 27 NUMBER OF PATENTS PUBLISHED (JANUARY 2015–JUNE 2026) 84
FIGURE 28 TOP APPLICANT COUNTRIES/REGIONS FOR MEDICAL DEVICES
(JANUARY 2015−JUNE 2026) 85
FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MEDICAL DEVICES 96
FIGURE 30 KEY BUYING CRITERIA FOR MEDICAL DEVICES 97
FIGURE 31 MEDICAL DEVICES MARKET: GEOGRAPHIC SNAPSHOT 117
FIGURE 32 NORTH AMERICA: MEDICAL DEVICES MARKET SNAPSHOT 119
FIGURE 33 ASIA PACIFIC: MEDICAL DEVICES MARKET SNAPSHOT 131
FIGURE 34 REVENUE ANALYSIS OF KEY PLAYERS IN MEDICAL DEVICES MARKET (2021–2025) 149
FIGURE 35 MARKET SHARE ANALYSIS OF KEY PLAYERS IN IN VITRO DIAGNOSTIC DEVICES MARKET (2025) 150
FIGURE 36 MARKET SHARE ANALYSIS OF KEY PLAYERS IN CARDIOVASCULAR DEVICES MARKET (2025) 151
FIGURE 37 MARKET SHARE ANALYSIS OF KEY PLAYERS IN ORTHOPEDIC DEVICES MARKET (2025) 151
FIGURE 38 MARKET SHARE ANALYSIS OF KEY PLAYERS IN DIABETES CARE DEVICES MARKET (2025) 152
FIGURE 39 MARKET SHARE ANALYSIS OF KEY PLAYERS IN ENDOSCOPY DEVICES MARKET (2025) 152
FIGURE 40 MEDICAL DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 155
FIGURE 41 MEDICAL DEVICES MARKET: COMPANY FOOTPRINT 156
FIGURE 42 MEDICAL DEVICES MARKET: COMPANY EVALUATION MATRIX
(STARTUPS/SMES), 2025 161
FIGURE 43 EV/EBITDA OF KEY VENDORS 165
FIGURE 44 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK
BETA OF KEY VENDORS 165
FIGURE 45 MEDICAL DEVICES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 166
FIGURE 46 MEDTRONIC PLC: COMPANY SNAPSHOT (2025) 176
FIGURE 47 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2025) 181
FIGURE 48 ABBOTT: COMPANY SNAPSHOT (2025) 187
FIGURE 49 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2025) 192
FIGURE 50 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2025) 196
FIGURE 51 STRYKER CORPORATION: COMPANY SNAPSHOT (2025) 202
FIGURE 52 B. BRAUN SE: COMPANY SNAPSHOT (2025) 205
FIGURE 53 SMITH & NEPHEW: COMPANY SNAPSHOT (2025) 209
FIGURE 54 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2025) 212
FIGURE 55 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2025) 217
FIGURE 56 RESEARCH DESIGN 235
FIGURE 57 PRIMARY SOURCES 238
FIGURE 58 PRIMARY BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 240
FIGURE 59 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS 241
FIGURE 60 TOP-DOWN APPROACH 241
FIGURE 61 BOTTOM-UP APPROACH 242
FIGURE 62 IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2026–2031) 243
FIGURE 63 MEDICAL DEVICES MARKET: CAGR PROJECTIONS 243
FIGURE 64 DATA TRIANGULATION METHODOLOGY 245
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們